Johnson & Johnson vs. Q32 Bio Inc. Common Stock
Johnson & Johnson and Q32 Bio Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | QTTB | |
|---|---|---|
| Market Cap | $644.82 billion | $246.19 million |
| Revenue (TTM) | $97.93 billion | — |
| Net Income (TTM) | $21.04 billion | — |
JNJ leads on 1 of 1 size & scale factors.
Valuation
| JNJ | QTTB | |
|---|---|---|
| P/E Ratio | 30.71 | — |
| Price / Book | 7.59 | — |
| Price / Sales | 6.58 | — |
JNJ and QTTB split the valuation factors evenly.
Profitability
| JNJ | QTTB | |
|---|---|---|
| Net Margin | 21.48% | — |
| Return on Equity | 24.76% | — |
JNJ and QTTB split the profitability factors evenly.
Dividend
| JNJ | QTTB | |
|---|---|---|
| Dividend Yield | 2.02% | — |
| Payout Ratio | 62.18 | — |
JNJ and QTTB split the dividend factors evenly.
Risk & Sentiment
| JNJ | QTTB | |
|---|---|---|
| Short Interest | 0.67% | 0.03% |
QTTB leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, QTTB overview, QTTB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.